| "Bacteroides symbiosus" Stevens 1956| [Clostridium] symbiosum| ATCC 14940| Bacteroides symbiosus| Clostridium symbiosum| Clostridium symbiosum (Stevens 1956) Kaneuchi et al. 1976| DSM 934| JCM 1297
Commensal organism: Clostridium symbiosum is considered a commensal bacterium, meaning it is typically found as part of the normal microbial community (microbiota) in the human gastrointestinal tract. In this context, it may play a role in various physiological processes such as digestion, nutrient metabolism, and immune modulation.
Role in gut ecology: Like other commensal bacteria, Clostridium symbiosum may contribute to the maintenance of a healthy microbial balance (microbial homeostasis) in the gut. It may interact with other microorganisms and host cells in the intestinal environment, influencing factors such as intestinal barrier function, inflammation, and susceptibility to infections.
Potential pathogenicity: While Clostridium symbiosum is generally considered benign in healthy individuals, some Clostridium species have the potential to cause diseases under certain circumstances. Clostridium symbiosum may possess virulence factors or pathogenic mechanisms that could lead to infections or other health impacts, particularly in individuals with underlying health conditions or compromised immune systems. However, specific information on the pathogenicity of Clostridium symbiosum is limited.
Research gaps: Due to limited research on Clostridium symbiosum, its role in human health and disease is not well-understood. Further studies are needed to elucidate its interactions with the host, its potential contributions to gut health, and any implications for human health and disease.
A lot more information is available when you are logged in and raise the display level
Other Sources for more information:
Statistics | NCBI | Data Punk | End Products Produced |
Different labs use different software to read the sample. See this post for more details.
One lab may say you have none, another may say you have a lot! - This may be solely due to the software they are using to estimate.
We deem lab specific values using values from the KM method for each specific lab to be the most reliable.
Lab | Frequency | UD-Low | UD-High | KM Low | KM High | Lab Low | Lab High | Mean | Median | Standard Deviation | Box Plot Low | Box Plot High | KM Percentile Low | KM Percentile High |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Other Labs | 2.47 | 0 | 0 | 1 | 3489 | 0 | 2102 | 548.3 | 236 | 793 | 30 | 790 | 0 %ile | 100 %ile |
thorne | 100 | 2 | 52 | 0 | 45 | 18.8 | 14 | 13.3 | 6 | 32 | 0 %ile | 100 %ile | ||
thryve | 95.85 | 44 | 7300 | 81 | 7042 | 0 | 13560 | 3948.9 | 2413 | 4903.7 | 0 | 8298 | 5.7 %ile | 90.8 %ile |
ubiome | 0.25 | 17 | 132 | 0 | 234 | 74.5 | 74 | 81.3 | 17 | 132 | 25 %ile | 50 %ile |
Source of Ranges | Low Boundary | High Boundary | Low Boundary %age | High Boundary %age |
---|---|---|---|---|
XenoGene | 0 | 5000 | 0 | 0.5 |
Thorne (20/80%ile) | 3.41 | 9.76 | 0.0003 | 0.001 |
Lab | Frequency Seen | Average | Standard Deviation | Sample Count | Lab Samples |
---|---|---|---|---|---|
BiomeSightRdp | 28.125 % | 0.054 % | 0.111 % | 9.0 | 32 |
bugspeak | 100 % | 0.033 % | % | 1.0 | 1 |
CosmosId | 65.625 % | 0.06 % | 0.077 % | 21.0 | 32 |
custom | 15.254 % | 0.012 % | 0.026 % | 9.0 | 59 |
es-xenogene | 6.897 % | 0.033 % | 0.045 % | 2.0 | 29 |
Microba | 3.571 % | 0.217 % | % | 1.0 | 28 |
SequentiaBiotech | 38.889 % | 0.027 % | 0.023 % | 14.0 | 36 |
Thorne | 81.111 % | 0.002 % | 0.001 % | 73.0 | 90 |
Thryve | 95.734 % | 0.382 % | 0.473 % | 1324.0 | 1383 |
uBiome | 0.253 % | 0.007 % | 0.008 % | 2.0 | 792 |
Click on Impact for information if high or low levels are causing the impact
Magnitude | Impact | Symptom |
---|
|
And display level must be raised above public.
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2024 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 Β§β―1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.